Cardiovascular events and all-cause mortality: effects of dual therapy intensification with insulin vs glucagon-like peptide-1 analogue

被引：0
|
作者：
Anyanwagu, U. [1 ]
Mamza, J. [1 ]
Mehta, R. [2 ]
Donnelly, R. [1 ]
Idris, I. [1 ]
Idris, I. [1 ]
机构：
[1] Univ Nottingham, Div Med Sci & Grad Entry Med, Nottingham NG7 2RD, England
[2] Univ Nottingham, Trent Res Design Serv, Nottingham NG7 2RD, England
来源：
DIABETOLOGIA | 2015年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
937
引用
收藏
页码：S452 / S452
页数：1
相关论文
共 50 条
  • [1] Cardiovascular events and all-cause mortality with insulin versus glucagon-like peptide-1 analogue in type 2 diabetes
    Anyanwagu, Uchenna
    Mamza, Jil
    Mehta, Rajnikant
    Donnelly, Richard
    Idris, Iskandar
    HEART, 2016, 102 (19) : 1581 - 1587
  • [2] Effect of Glucagon-like Peptide-1 Receptor Agonists on All-cause Mortality and Cardiovascular Outcomes: A Meta-analysis
    Peterson, Shaylee C.
    Barry, Arden R.
    CURRENT DIABETES REVIEWS, 2018, 14 (03) : 273 - 279
  • [3] Cardiovascular and hemodynamic effects of glucagon-like peptide-1
    Adam G. Goodwill
    Kieren J. Mather
    Abass M. Conteh
    Daniel J. Sassoon
    Jillian N. Noblet
    Johnathan D. Tune
    Reviews in Endocrine and Metabolic Disorders, 2014, 15 : 209 - 217
  • [4] Glucagon-Like Peptide-1 and its Cardiovascular Effects
    Kyung-Sun Heo
    Keigi Fujiwara
    Jun-ichi Abe
    Current Atherosclerosis Reports, 2012, 14 : 422 - 428
  • [5] Glucagon-Like Peptide-1 and its Cardiovascular Effects
    Heo, Kyung-Sun
    Fujiwara, Keigi
    Abe, Jun-ichi
    CURRENT ATHEROSCLEROSIS REPORTS, 2012, 14 (05) : 422 - 428
  • [6] Cardiovascular and hemodynamic effects of glucagon-like peptide-1
    Goodwill, Adam G.
    Mather, Kieren J.
    Conteh, Abass M.
    Sassoon, Daniel J.
    Noblet, Jillian N.
    Tune, Johnathan D.
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2014, 15 (03): : 209 - 217
  • [7] Mechanisms for the cardiovascular effects of glucagon-like peptide-1
    Poudyal, H.
    ACTA PHYSIOLOGICA, 2016, 216 (03) : 277 - 313
  • [8] All-Cause Mortality and Cardiovascular Outcomes with Glucagon-Like Peptide-1 Receptor Agonists in People with Type 2 Diabetes and Systolic Heart Failure
    Vignarajah, Aravinthan
    Vigneswaramoorthy, Nishanthi
    Shah, Gautam
    CIRCULATION, 2024, 150
  • [9] The Cardiovascular Biology of Glucagon-like Peptide-1
    Drucker, Daniel J.
    CELL METABOLISM, 2016, 24 (01) : 15 - 30
  • [10] Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
    Kang, Yu Mi
    Jung, Chang Hee
    ENDOCRINOLOGY AND METABOLISM, 2016, 31 (02) : 258 - 274
12345